RE: partnership with WuXi ATU22 Dec 2021 17:16
WuXi Biologics announced the completion of three acquisitions in one go.
The investment community was informed that on May 7, WuXi Biologics officially announced the completion of three acquisitions, involving Bayer's original solution production base in Wuppertal, Germany, Pfizer China's original solution and preparation production base in Hangzhou, and China's contracted R&D and production of biopharmaceuticals. Enterprise (CDMO) Suqiao Biological
Found this from a chinese website, WuXi Biologics is WuXI ATU
I think it highly likely this company will buy out HEMO at some stage